We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




No Intensive Care for Dutch Babies Under 25 Weeks

By HospiMedica staff writers
Posted on 19 Jul 2001
According to a news article in the British Medical Journal (BMJ), doctors in The Netherlands have decided that preterm babies born prior to 25 weeks of gestation will not receive active intensive treatment because research shows they have a poor prognosis. More...
Many babies born earlier than 25 weeks do not survive, and those who do survive face the likelihood of developing serious problems later on.

The University Medical Center in Leiden (The Netherlands) decided to increase the limit from 24 to 25 weeks because of a study conducted by the center on premature births from 1996-1997. This study revealed that out of all preterm babies born at 23 and 24 weeks, 66% died. Moreover, half of those who survived suffered from severe mental or physical handicaps by the time they were two years old. In contrast, 60% of preterm babies born at 35 weeks died and those who survived had fewer handicaps.

The decision to change the limit was made just as the results of another study were made public. This was a 14-year joint study conducted by the Leiden center and a Dutch research group that collected data on 1,338 babies born at 32 weeks or sooner or whose birth weight was 1,500 g or less. The outcomes showed that 30% of the babies died within two years, and 10% of these had a severe disability or handicap. Although by school age the others had no severe disability, half had serious difficulties in their everyday life. "The burden of these mild developmental abnormalities and behavioral and learning disorders increases with age,” concluded the authors.

The chairman of the ethical committee of the Dutch Association of Pediatric Medicine, Dr. Louis Kollee, said that the 25 weeks was not a sharp cut-off point but, rather, a guideline not to immediately offer intensive treatment following delivery but to consider each case on its own merits.





Related Links:
British Medical Journal

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.